In both pancreatic cancer cell lines, we found that the synthetic SIFα showed a significantly higher activity than did wild type IFNα in potentiating the antitumor cell growth mediated by a low dose of GEM (Fig. 4, p < 0.01). The gene discussed is IFNA1; the disease is familial pancreatic carcinoma.